Abstract:Yanzhi Feng, 1– 4, &ast Litao Liang, 1– 4, &ast Wenbo Jia, 1– 4 Jinyi Wang, 1– 4 Chao Xu, 1– 4 Deming Zhu, 1– 4 Bin Xu, 1– 4 Wenhu Zhao, 1– 4 Xiangyu Ling, 1– 4 Yongping Zhou, 5 Lianbao Kong, 1– 4, &ast Wenzhou Ding 1– 4, &ast 1 Hepatobiliary Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 2 Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, National Health Commission Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu, People's Republic of China; 3 Jiangsu Provincial Medical Innovation Center, Nanjing, Jiangsu, People's Republic of China; 4 Jiangsu Provincial Medical Key Laboratory, Nanjing, Jiangsu, People's Republic of China; 5 Jiangnan University Medical Center, JUMC, Department of Hepatobiliary, Wuxi, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wenzhou Ding; Lianbao Kong, Hepatobiliary Centre, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China, Email ; Background: Circular RNAs (circRNAs) have been shown to play a crucial role in the initiation and development of Hepatocellular carcinoma (HCC). However, the mechanism and function of circ_0007386 in HCC are still unknown. Methods: Circ_0007386 expression level in HCC tissues, and HCC cell lines was further analyzed by qRT-PCR. Agarose gel electrophoresis and Sanger sequencing were used to figure out the structure of circ_0007386. The involvement of circ_0007386 in HCC development was evaluated by experimental investigations conducted in both laboratory settings (in vitro) and living organisms (in vivo). RNA immunoprecipitation, Western blotting, luciferase reporter assay and fluorescence in situ hybridization (FISH) were applied for finding out the interaction among circ_0007386, miR-507 and CCNT2. To assess the connection between circ_0007386 and lenvatinib resistance, lenvatinib-resistant HCC cell lines were employed. Results: The expression of circ_0007386 was found to increase in HCC tissues, and it was observed to be associated with a worse prognosis. Overexpression of circ_0007386 stimulated HCC cells proliferation, invasion, migration and the epithelial–mesenchymal transition (EMT) while silencing of circ_0007386 resulted in the opposite effect. Mechanistic investigations revealed that circ_0007386 acted as a competing endogenous RNA of miR-507 to prevent CCNT2 downregulation. Downregulating miR-507 or overexpressing CCNT2 could reverse phenotypic alterations that originated from inhibiting of circ_0007386. Importantly, circ_0007386 determines the resistance of hepatoma cells to lenvatinib treatment. Conclusion: Circ_0007386 advanced HCC progression and lenvatinib resistance through the miR-507/ CCNT2 axis. Meanwhile, circ_0007386 served as a potential biomarker and therapeutic target in HCC patients. Keywords: hepatocellular carcinoma, circ_0007386, miR-507, CCNT2, Lenvatinib Graphical Hepatocellular cancer (HCC) is the fourth leading cause of cancer death worldwide and the second largest cause of impaired cancer life expectancy worldwide, which emphasizes the significant disease burden of liver cancer. 1 The treatment of HCC is a full-spectrum therapy modality based on aggressive resection, whereas there are no effective molecular therapeutic targets. Despite various attempts to improve treatment choices, HCC still has a dismal prognosis. 2 Therefore, research on the genetic and molecular basis of HCC development is critical. Circular RNAs (circRNAs), noncoding RNAs (ncRNAs), are regarded as modulators of gene expression, m6A modification and RNA binding proteins. Furthermore, current studies have demonstrated that circRNAs can behave as molecular sponges for miRNA regulation and interact with RNA-binding proteins to modulate transcriptional processes. 3–5 An increasing number of circRNAs have been linked to tumor growth, suggesting that they may play a crucial role in the pathogenesis of many different tumor types. 6–8 The above findings suggest that circRNAs hold significant research potential. Nevertheless, a considerable number of circRNAs remain to be identified and investigated. Studies have demonstrated the significance of circRNAs produced from CRIM1 in a variety of carcinomas, including bladder cancer, ovarian cancer, and nasopharyngeal carcinoma. 9–11 However, the function of -Abstract Truncated-

CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinoma

Integrated Multiomics Reveals Silencing of Has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis

Circular RNA Circrims1 Acts As a Sponge of Mir-433-3p to Promote Bladder Cancer Progression by Regulating CCAR1 Expression.

CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma

Circular RNA Circ_0008934 Promotes Hepatocellular Carcinoma Growth and Metastasis Through Modulating Mir-1305/Tmtc3 Axis.

CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p/PTK2/AKT axis

N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1

CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma

CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis

Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation

CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer

CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR-3191-5p

Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42

Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

circHMGCS1–016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma

IL‐6–induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma

Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis

Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25

ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway

Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis

CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ